Evidence map›Paper›PMID 30063762›Full record

ArticlePloS one2018

Oat beta-glucan as a dietary supplement for dogs.

Lívia Geraldi Ferreira, Mariangela Endrighi, Karen Guttenkunst Lisenko, Maiara Rodrigues Duarte de Oliveira, Mateus Resende Damasceno, Jelieny Aparecida Claudino, Pamella Godinho Gutierres, Ana Paula Peconick, Flávia Maria de Oliveira Borges Saad, Márcio Gilberto Zangeronimo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Effects of a single-cell protein source fromFrontiers in veterinary science · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Effects of feedingFrontiers in veterinary science · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Lívia Geraldi FerreiraVeterinary Medicine Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Mariangela EndrighiVeterinary Medicine Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Karen Guttenkunst LisenkoAnimal Science Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Maiara Rodrigues Duarte de OliveiraAnimal Science Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Mateus Resende DamascenoAnimal Science Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Jelieny Aparecida ClaudinoAnimal Science Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Pamella Godinho GutierresAnimal Science Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Ana Paula PeconickVeterinary Medicine Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Flávia Maria de Oliveira Borges SaadAnimal Science Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.
Márcio Gilberto ZangeronimoVeterinary Medicine Department, Federal University of Lavras, Lavras, Minas Gerais, Brazil.ORCID 0000-0002-3530-9345
Universidade Federal de Lavras · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the effects of oat beta-glucan supplementation on metabolic, physiological, immunological and nutritional variables in adult dogs. Fourteen dogs were fed a control diet or a diet supplemented with 1% beta-glucan during 71 days. Serum concentrations of glucose, total cholesterol and lipoprotein fractions, as well as plasma concentrations of peptide YY and ghrelin, were determined. In addition, coefficient of total tract apparent macronutrient digestibility (CTTAD), food intake and fecal output, score, and pH were evaluated. For evaluation of immunological variables, serum concentrations of interleukin-4 and interferon gamma were determined on days 0, 57 and 71, which corresponded to blood collection prior to beta-glucan supplementation, and at 7 and 14 days post first and second dose of vaccination (Pneumodog®, Merial, Campinas, Brazil), respectively. Animals fed the supplemented diet showed (P<0.05) lower serum concentrations of total cholesterol and low and very low density lipoproteins, lower coefficients of total tract apparent digestibility of dry matter, organic matter, mineral matter and ether extract, higher fecal output and lower fecal consistency, as well as a tendency (P = 0.07) of decreasing the coefficient of total tract apparent digestibility of crude protein. Moreover, the supplemented diet resulted in lower number of red blood cells, hematocrit percentage and hemoglobin concentration 21 days post-vaccination as well as lower serum concentration of interleukin-4 seven days post-vaccination (P<0.05). It is concluded that oat beta-glucan extract can be used as a dietary supplement for dogs at a dose of 10 g/kg of food, being effective in reducing blood concentrations of total cholesterol, LDL-c and VLDL-c as well as CTTAD of nutrients, demonstrating a potential to be used in the feeding of obese animals. In addition, by reducing the predominance of a Th2 response, oat beta-glucan can positively modulate the vaccine response of animals.

Indexed as

AvenaDietary SupplementsDogsAnimal FeedAnimal Nutritional Physiological PhenomenaAnimalsbeta-GlucansCholesterolEatingFecesInterferon-gammaInterleukin-4ObesityVaccinationbeta-GlucansCholesterolInterferon-gammaInterleukin-4

Identifiers

PMID30063762
PMCPMC6067736
OpenAlexW2885310393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.